C07K 16/245
Il-1
Official title: {il-1}
C07K16/245 (Il-1) appears on 227 US grants and 495 published applications in this corpus.
Search patents in C07K- Granted patents
- 227
- Published applications
- 495
- Assignees
- 159
- Inventors
- 650
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 2 | 2 |
| 2003 | 2 | 9 |
| 2004 | 0 | 5 |
| 2005 | 3 | 11 |
| 2006 | 4 | 4 |
| 2007 | 4 | 10 |
| 2008 | 1 | 15 |
| 2009 | 13 | 20 |
| 2010 | 12 | 26 |
| 2011 | 9 | 16 |
| 2012 | 9 | 28 |
| 2013 | 19 | 27 |
| 2014 | 17 | 47 |
| 2015 | 17 | 26 |
| 2016 | 18 | 27 |
| 2017 | 15 | 20 |
| 2018 | 9 | 15 |
| 2019 | 8 | 21 |
| 2020 | 8 | 27 |
| 2021 | 12 | 33 |
| 2022 | 9 | 26 |
| 2023 | 4 | 31 |
| 2024 | 11 | 20 |
| 2025 | 6 | 14 |
| 2026 | 10 | 15 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Antibody that binds to VEGF and IL-1BETA and methods of use15 Sep 2026US 12,735,477 B2Hoffmann-La Roche Inc.
- Gout flare prevention methods using IL-1β blockers25 Aug 2026US 12,715,915 B2
- Anti-IL-1β antibody therapy in arrhythmogenic cardiomyopathy (ACM)18 Aug 2026US 12,708,665 B2Beth Israel Deaconess Medical Center, Inc.
- Multivalent peptide conjugates for sustained intra-articular treatment of joint inflammation14 Apr 2026US 12,599,663 B2Valitor, Inc.
- Methods for treating breast cancer24 Mar 2026US 12,582,628 B2Olatec Therapeutics LLC
- Intra-striatal co-transplantation of autologous treg and mda cells in parkinson's disease cell therapy8 Oct 2026US 2026/0306543 A1The McLean Hospital Corporation
- Use of goflikicept for the treatment of idiopathic recurrent pericarditis20 Aug 2026US 2026/0242460 A1R-Pharm Overseas Inc.
- Antibodies and polypeptides comprising variant fc regions20 Aug 2026US 2026/0242497 A1
- Methods of treating hidradenitis suppurativa30 Jul 2026US 2026/0217816 A1AbbVie Deutschland GmbH & Co. KG
- True human antibody specific for interleukin 1 alpha2 Jul 2026US 2026/0184779 A1Xbiotech, Inc.
Most cited
By later US patents
- Interleukin-1α antibodies1,029US 8,034,337 B2Xbiotech, Inc. · 2011
- Dual variable domain immunoglobulin and uses thereof391US 7,612,181 B2Abbott Laboratories · 2009
- Dual variable domain immunoglobulin and uses thereof187US 8,258,268 B2Abbott Laboratories · 2012
- Multiple cytokine protein complexes145US 6,617,135 B1EMD Lexigen Research Center Corp. · 2003
- Dual variable domain immunoglobulins and uses thereof89US 8,716,450 B2AbbVie Inc. · 2014